The effect of TGF-β receptor binding peptides on smooth muscle cells

被引:21
作者
Michon, IN [1 ]
Penning, LC [1 ]
Molenaar, TJM [1 ]
van Berkel, TJC [1 ]
Biessen, EAL [1 ]
Kuiper, J [1 ]
机构
[1] Leiden Univ, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands
关键词
phage display; TGF-beta; vascular smooth muscle cell; chemotaxis; peptides; extracellular matrix; PAI-1; osteopontin; alpha smooth muscle actin;
D O I
10.1016/S0006-291X(02)00378-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TGF-beta1 is a potent regulator of vascular smooth muscle cell (VSMC) proliferation, migration, and extracellular matrix (ECM) synthesis. In this study, we selected two peptides, IM-1 and IM-2, that bind to the TGF-beta type II receptor (TGF-beta RII) using phage display. IM-1 and IM-2 bind to the TGF-beta RII, with a K-d of 1 muM. Like TGF-beta, IM-1 induced VSMC chemotaxis and PAI-1 mRNA expression, as determined using Boyden chambers and real time quantitative PCR. In contrast, IM-2 had no effect on VSMC chemotaxis or PAI-1 induction. Induction of ECM synthesis, involving proteins such as osteopontin and alpha-smooth muscle actin, was determined by ELISA. Osteopontin expression was inhibited by both peptides, but TGF-beta-induced alpha-smooth muscle actin expression could only be inhibited by IM-1. In conclusion, IM-1 activity on VSMC is agonistic with TGF-beta, except for ECM synthesis, whereas the IM-2 peptide is antagonistic for some examined TGF-beta functions. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1279 / 1286
页数:8
相关论文
共 48 条
  • [1] EFFECTS OF TRANSFORMING GROWTH FACTOR-BETA-1 ON HUMAN ARTERIAL SMOOTH-MUSCLE CELLS-INVITRO
    BJORKERUD, S
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (04): : 892 - 902
  • [2] Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions -: Colocalization implicates TGF-β in fibrofatty lesion development
    Bobik, A
    Agrotis, A
    Kanellakis, P
    Dilley, R
    Krushinsky, A
    Smirnov, V
    Tararak, E
    Condron, M
    Kostolias, G
    [J]. CIRCULATION, 1999, 99 (22) : 2883 - 2891
  • [3] Braestrup C, 1982, Prog Clin Biol Res, V90, P227
  • [4] CHARACTERIZATION OF DISTINCT FUNCTIONAL DOMAINS OF TRANSFORMING GROWTH-FACTOR-BETA
    BURMESTER, JK
    QIAN, SW
    ROBERTS, AB
    HUANG, A
    AMATAYAKULCHANTLER, S
    SUARDET, L
    ODARTCHENKO, N
    MADRI, JA
    SPORN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8628 - 8632
  • [5] Mutational analysis of a transforming growth factor-β receptor binding site
    Burmester, JK
    Qian, SW
    Ohlsen, D
    Phan, S
    Sporn, MB
    Roberts, AB
    [J]. GROWTH FACTORS, 1998, 15 (03) : 231 - 242
  • [6] CAMPBELL GR, 1988, ARCH PATHOL LAB MED, V112, P977
  • [7] Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions
    de Vries, HE
    Buchner, B
    van Berkel, TJC
    Kuiper, J
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) : 638 - 645
  • [8] Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI-1) using random peptide phage-display libraries
    Gårdsvoll, H
    van Zonneveld, AJ
    Holm, A
    Eldering, E
    van Meijer, M
    Dano, K
    Pannekoek, H
    [J]. FEBS LETTERS, 1998, 431 (02) : 170 - 174
  • [9] OSTEOPONTIN IS ELEVATED DURING NEOINTIMA FORMATION IN RAT ARTERIES AND IS A NOVEL COMPONENT OF HUMAN ATHEROSCLEROTIC PLAQUES
    GIACHELLI, CM
    BAE, N
    ALMEIDA, M
    DENHARDT, DT
    ALPERS, CE
    SCHWARTZ, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1686 - 1696
  • [10] Grainger DJ, 1998, J CELL SCI, V111, P2977